Biosynthesis and expression of VE-cadherin is regulated by the PI3K/mTOR signaling pathway

Molecular Immunology

Volumn 46, Issue 5, 2009, Pages 866-872

  Bieri, Michael ^a   Oroszlan, Melinda ^a   Zuppinger, Christian ^a   Mohacsi, Paul J ^a  

^a BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Adherens junction; Endothelial cells; mTOR; PI3K; Vascular endothelial cadherin

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; TACROLIMUS; VASCULAR ENDOTHELIAL CADHERIN; WORTMANNIN;

ANTIGEN EXPRESSION; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIGENS, CD; CADHERINS; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; MICE; MICE, KNOCKOUT; PROTEIN KINASES; SIGNAL TRANSDUCTION;

MAMMALIA; MUS;

EID: 59249090110     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.09.011     Document Type: Article

References (19)

1. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oostuyse B., Dewerchin M., Zanetti A., Angellilo A., Mattot V., Nuyens D., Lutgens E., Clotman F., de Ruiter M.C., Gittenberger-de Groot A., Poelmann R., Lupu F., Herbert J.M., Collen D., and Dejana E. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98 (1999) 147-157
2. Dejana E. Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5 (2004) 261-270
3. Deleuze V., Chalhoub E., El-Hajj R., Dohet C., Le Clech M., Couraud P.O., Huber P., and Mathieu D. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells. Mol. Cell. Biol. 27 (2007) 2687-2697
4. Esser S., Lampugnani M.G., Corada M., Dejana E., and Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J. Cell. Sci. 111 Pt 13 (1998) 1853-1865
5. Gingras A.C., Raught B., and Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15 (2001) 807-826
6. Gooding J.M., Yap K.L., and Ikura M. The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures. Bioessays 26 (2004) 497-511
7. Grazia Lampugnani M., Zanetti A., Corada M., Takahashi T., Balconi G., Breviario F., Orsenigo F., Cattelino A., Kemler R., Daniel T.O., and Dejana E. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J. Cell Biol. 161 (2003) 793-804
8. Ha C.H., Bennett A.M., and Jin Z.G. A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor. J. Biol. Chem. 283 (2008) 7261-7270
9. Jaffe E.A., Nachman R.L., Becker C.G., and Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52 (1973) 2745-2756
10. Kunz J., and Hall M.N. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. Trends Biochem. Sci. 18 (1993) 334-338
11. Lampugnani M.G., Orsenigo F., Gagliani M.C., Tacchetti C., and Dejana E. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J. Cell Biol. 174 (2006) 593-604
12. Mohacsi P.J., Tuller D., Hulliger B., and Wijngaard P.L. Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor. J. Heart Lung Transplant 16 (1997) 484-492
13. Morris R.E. Rapamycin: FK506's fraternal twin or distant cousin?. Immunol. Today 12 (1991) 137-140
14. Pece S., Chiariello M., Murga C., and Gutkind J.S. Activation of the protein kinase Akt/PKB by the formation of E-cadherin-mediated cell-cell junctions. Evidence for the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion complex. J. Biol. Chem. 274 (1999) 19347-19351
15. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., and Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22 (2006) 159-168
16. Shiota C., Woo J.T., Lindner J., Shelton K.D., and Magnuson M.A. Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev Cell 11 (2006) 583-589
17. Shore E.M., and Nelson W.J. Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. J. Biol. Chem. 266 (1991) 19672-19680
18. Vincent P.A., Xiao K., Buckley K.M., and Kowalczyk A.P. VE-cadherin: adhesion at arm's length. Am. J. Physiol. Cell Physiol. 286 (2004) C987-C997
19. Yang Z.Z., Tschopp O., Di-Poi N., Bruder E., Baudry A., Dummler B., Wahli W., and Hemmings B.A. Dosage-dependent effects of Akt1/protein kinase Balpha (PKBalpha) and Akt3/PKBgamma on thymus, skin, and cardiovascular and nervous system development in mice. Mol Cell Biol 25 (2005) 10407-10418